A detailed history of Robeco Institutional Asset Management B.V. transactions in Innoviva, Inc. stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 28,742 shares of INVA stock, worth $496,661. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,742
Previous 45,022 36.16%
Holding current value
$496,661
Previous $738,000 24.93%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$16.33 - $20.04 $265,852 - $326,251
-16,280 Reduced 36.16%
28,742 $554,000
Q2 2024

Jul 22, 2024

SELL
$14.4 - $16.4 $6.15 Million - $7.01 Million
-427,255 Reduced 90.47%
45,022 $738,000
Q1 2024

Apr 24, 2024

SELL
$14.56 - $16.78 $134,214 - $154,678
-9,218 Reduced 1.91%
472,277 $7.2 Million
Q4 2023

Feb 14, 2024

BUY
$12.32 - $16.27 $35,383 - $46,727
2,872 Added 0.6%
481,495 $7.72 Million
Q4 2023

Feb 08, 2024

SELL
$12.32 - $16.27 $414,025 - $546,769
-33,606 Reduced 6.56%
478,623 $481 Million
Q3 2023

Oct 23, 2023

SELL
$12.37 - $13.89 $239,062 - $268,438
-19,326 Reduced 3.64%
512,229 $6.65 Million
Q2 2023

Jul 24, 2023

BUY
$11.39 - $13.72 $121,371 - $146,200
10,656 Added 2.05%
531,555 $6.77 Million
Q4 2022

Feb 06, 2023

BUY
$11.8 - $13.78 $19,104 - $22,309
1,619 Added 0.31%
520,899 $6.9 Million
Q3 2022

Dec 01, 2022

SELL
$11.61 - $15.22 $202,629 - $265,634
-17,453 Reduced 3.25%
519,280 $6.03 Million
Q3 2022

Oct 26, 2022

SELL
$11.61 - $15.22 $202,629 - $265,634
-17,453 Reduced 3.25%
519,280 $6.03 Million
Q2 2022

Dec 01, 2022

BUY
$14.32 - $19.88 $1.81 Million - $2.51 Million
126,350 Added 30.79%
536,733 $7.92 Million
Q2 2022

Jul 27, 2022

BUY
$14.32 - $19.88 $1.81 Million - $2.51 Million
126,350 Added 30.79%
536,733 $7.92 Million
Q1 2022

Dec 01, 2022

BUY
$15.39 - $20.25 $4.29 Million - $5.65 Million
278,855 Added 212.01%
410,383 $7.94 Million
Q1 2022

Apr 26, 2022

BUY
$15.39 - $20.25 $4.29 Million - $5.65 Million
278,855 Added 212.01%
410,383 $7.94 Million
Q4 2021

Dec 01, 2022

BUY
$15.91 - $18.72 $277,677 - $326,720
17,453 Added 15.3%
131,528 $2.27 Million
Q4 2021

Jan 31, 2022

BUY
$15.91 - $18.72 $277,677 - $326,720
17,453 Added 15.3%
131,528 $2.27 Million
Q2 2021

Dec 01, 2022

SELL
$11.45 - $13.96 $437,607 - $533,537
-38,219 Reduced 25.1%
114,075 $1.53 Million
Q2 2021

Jul 28, 2021

SELL
$11.45 - $13.96 $437,607 - $533,537
-38,219 Reduced 25.1%
114,075 $1.53 Million
Q1 2021

Dec 01, 2022

SELL
$11.06 - $12.87 $4.06 Million - $4.72 Million
-366,986 Reduced 70.67%
152,294 $1.82 Million
Q1 2021

Apr 23, 2021

SELL
$11.06 - $12.87 $2.98 Million - $3.47 Million
-269,510 Reduced 63.89%
152,294 $1.82 Million
Q4 2020

Dec 01, 2022

SELL
$9.33 - $12.48 $909,451 - $1.22 Million
-97,476 Reduced 18.77%
421,804 $5.23 Million
Q4 2020

Jan 28, 2021

SELL
$9.33 - $12.48 $1.2 Million - $1.6 Million
-128,268 Reduced 23.32%
421,804 $5.23 Million
Q3 2020

Oct 29, 2020

BUY
$10.33 - $14.49 $674,714 - $946,428
65,316 Added 13.47%
550,072 $5.75 Million
Q2 2020

Jul 20, 2020

BUY
$11.49 - $15.26 $1.59 Million - $2.12 Million
138,663 Added 40.07%
484,756 $6.78 Million
Q1 2020

Apr 30, 2020

BUY
$8.11 - $15.23 $2.81 Million - $5.27 Million
346,093 New
346,093 $4.07 Million
Q2 2019

Jul 19, 2019

SELL
$13.1 - $14.95 $4.13 Million - $4.72 Million
-315,527 Closed
0 $0
Q1 2019

May 02, 2019

BUY
$13.69 - $20.06 $919,543 - $1.35 Million
67,169 Added 27.05%
315,527 $4.43 Million
Q4 2018

Feb 08, 2019

BUY
$13.96 - $18.26 $469,251 - $613,791
33,614 Added 15.65%
248,358 $4.3 Million
Q3 2018

Oct 25, 2018

BUY
$13.63 - $15.7 $1.2 Million - $1.38 Million
88,183 Added 69.68%
214,744 $3.27 Million
Q2 2018

Aug 03, 2018

BUY
$13.44 - $17.59 $265,117 - $346,980
19,726 Added 18.46%
126,561 $1.75 Million
Q3 2017

Oct 17, 2017

BUY
$12.06 - $14.12 $1.29 Million - $1.51 Million
106,835
106,835 $1.51 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.2B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.